ClinicaSpace.com
Clinical Research
News & Careers
 
Search the Site
    
 
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login           Employers:  Register | Login   

By Industry | By Industry Segment | By Services and Suppliers | By Location | Profile Search
 Company Profile

 

BioMarin Pharmaceutical Inc. 

105 Digital Drive

Novato  California  94949  U.S.A.
Phone: 415-506-6700 Fax: 415-382-7427


SEARCH JOBS


Industry
Biotechnology






 Company News
BioMarin (BMRN) Completes Rolling NDA Submission To FDA For Drisapersen For Treatment Of Duchenne Muscular Dystrophy Amenable To Exon 51 Skipping 4/27/2015 7:52:06 AM
BioMarin (BMRN) Presents Data On Duchenne Muscular Dystrophy At The 67th American Academy of Neurology Annual Meeting 4/23/2015 7:07:56 PM
BioMarin (BMRN) Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) 4/22/2015 7:56:38 AM
BioMarin (BMRN) To Host First Quarter 2015 Financial Results Conference Call And Webcast On Thursday, April 30 At 4:30pm ET 4/15/2015 3:26:51 PM
EXCLUSIVE: Shire (SHPGY) Buyout of BioMarin (BMRN) "Seems Obvious," Source Close to the Deal Tells BioSpace (DHX) 3/30/2015 4:23:40 PM
BioMarin (BMRN) Announces One Oral And 7 Poster Presentations At The 2015 American College Of Medical Genetics And Genomics Annual Clinical Genetics Meeting 3/30/2015 1:25:51 PM
BioMarin (BMRN) Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) 3/18/2015 7:52:05 AM
Myriad Genetics, Inc. (MYGN) And BioMarin (BMRN) Expand Collaboration To Evaluate Mychoice HRD As A Companion Diagnostic For Talazoparib 3/17/2015 7:45:05 AM
BioMarin (BMRN) Announces Fourth Quarter And Full Year 2014 Financial Results 2/26/2015 7:38:24 AM
BioMarin (BMRN) Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) 2/23/2015 7:21:59 AM
12345678910...